Mesoporous silica nanoparticles (MSNs) were explored as a carrier material for the stable
isotope 165Ho and, after neutron capture, its subsequent therapeutic radionuclide, 166Ho …

Mesoporous silica MCM-41 nanoparticles containing the stable isotope holmium-165
(165Ho) were prepared by exposing the approximately 400nm particles to an aqueous …

Nanoparticles containing stable holmium ((165) Ho) are prepared by nanotemplate
engineering and subsequently irradiated in a neutron flux to yield (166) Ho, a beta-emitting …

Radionuclide therapy with nano-sized carriers is a very promising approach to treat various
types of cancer. The preparation of radioactive nanocarriers can be achieved with minimum …

Traditional chelator-based radio-labeled nanoparticles and positron emission tomography
(PET) imaging are playing vital roles in the field of nano-oncology. However, their long-term …

Peritoneal metastasis is a major cause of morbidity and mortality in ovarian cancer. While
intraperitoneal chemotherapy and radiotherapy have shown favorable clinical results, both …

Colorectal cancer is one of the most significant types of cancer, ranking second in the
world's mortality cases. As colorectal cancer is often diagnosed at a late stage of disease …

The current approaches used for the treatment of cancer face some clinical limitations such
as induction of severe side effects, multidrug resistance (MDR), and low specificity toward …

We have constructed a theranostic drug delivery system, composed of a carrier and a drug.
Europium (Eu 3+) and gadolinium (Gd 3+) were doped into mesoporous silica nanoparticles …

Mesoporous silica nanoparticles are modified with dual targeting ligands, ie, folic acid and
dexamethasone, to construct a cancer-cell-specific nuclear-targeted delivery system. The …